| Dr Joel Ryon, MD | |
|
407 S White St Ste 103, Mount Pleasant, IA 52641-2263 | |
| (319) 385-6770 | |
| (319) 385-5409 |
| Full Name | Dr Joel Ryon |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 20 Years |
| Location | 407 S White St Ste 103, Mount Pleasant, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063523728 | NPI | - | NPPES |
| 0450445 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | R-7242 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Great River Hospice | West burlington, IA | Hospice |
| Great River Medical Center | West burlington, IA | Hospital |
| Henry County Health Center | Mount pleasant, IA | Hospital |
| Oakview Nursing And Rehabilitation | Burlington, IA | Nursing home |
| Savannah Heights | Mount pleasant, IA | Nursing home |
| New London Specialty Care | New london, IA | Nursing home |
| Azria Health Prairie Ridge | Mediapolis, IA | Nursing home |
| Sunrise Terrace Nursing & Rehabilitation Center | Winfield, IA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Henry County Health Center Inc | 9638570740 | 20 |
News Archive
Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services announces its financial results for the three- and six-month periods ended September 30, 2010.
Meridian Bioscience, Inc., Cincinnati, Ohio announced today that Meridian Bioscience Europe srl, Milan, Italy has signed an agreement with BÜHLMANN Laboratories AG, Schönenbuch, Switzerland for distribution in Italy of an innovative test for inflammatory conditions of the intestine, Quantum Blue® Calprotectin.
Surprising findings by Queen's University researchers have shed new light on how the 'sunshine vitamin' - D - increasingly used to treat and prevent cancer and other diseases is broken down by our bodies.
In a discussion paper given to the State Government, Alzheimer's Australia NSW estimates the number of Australians diagnosed with dementia will rise from 280,000 to around 943,000 by 2050. Of these, 303,500 people will be from NSW.
› Verified 8 days ago
| Entity Name | Southeast Iowa Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164433884 PECOS PAC ID: 3870496417 Enrollment ID: O20040130000139 |
News Archive
Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services announces its financial results for the three- and six-month periods ended September 30, 2010.
Meridian Bioscience, Inc., Cincinnati, Ohio announced today that Meridian Bioscience Europe srl, Milan, Italy has signed an agreement with BÜHLMANN Laboratories AG, Schönenbuch, Switzerland for distribution in Italy of an innovative test for inflammatory conditions of the intestine, Quantum Blue® Calprotectin.
Surprising findings by Queen's University researchers have shed new light on how the 'sunshine vitamin' - D - increasingly used to treat and prevent cancer and other diseases is broken down by our bodies.
In a discussion paper given to the State Government, Alzheimer's Australia NSW estimates the number of Australians diagnosed with dementia will rise from 280,000 to around 943,000 by 2050. Of these, 303,500 people will be from NSW.
› Verified 8 days ago
| Entity Name | Henry County Soldiers' And Sailors' Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467404103 PECOS PAC ID: 7911893169 Enrollment ID: O20040224001279 |
News Archive
Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services announces its financial results for the three- and six-month periods ended September 30, 2010.
Meridian Bioscience, Inc., Cincinnati, Ohio announced today that Meridian Bioscience Europe srl, Milan, Italy has signed an agreement with BÜHLMANN Laboratories AG, Schönenbuch, Switzerland for distribution in Italy of an innovative test for inflammatory conditions of the intestine, Quantum Blue® Calprotectin.
Surprising findings by Queen's University researchers have shed new light on how the 'sunshine vitamin' - D - increasingly used to treat and prevent cancer and other diseases is broken down by our bodies.
In a discussion paper given to the State Government, Alzheimer's Australia NSW estimates the number of Australians diagnosed with dementia will rise from 280,000 to around 943,000 by 2050. Of these, 303,500 people will be from NSW.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joel Ryon, MD 621 S Illinois Ave, Suite 103, Mason City, IA 50401-5489 Ph: (641) 494-3041 | Dr Joel Ryon, MD 407 S White St Ste 103, Mount Pleasant, IA 52641-2263 Ph: (319) 385-6770 |
News Archive
Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services announces its financial results for the three- and six-month periods ended September 30, 2010.
Meridian Bioscience, Inc., Cincinnati, Ohio announced today that Meridian Bioscience Europe srl, Milan, Italy has signed an agreement with BÜHLMANN Laboratories AG, Schönenbuch, Switzerland for distribution in Italy of an innovative test for inflammatory conditions of the intestine, Quantum Blue® Calprotectin.
Surprising findings by Queen's University researchers have shed new light on how the 'sunshine vitamin' - D - increasingly used to treat and prevent cancer and other diseases is broken down by our bodies.
In a discussion paper given to the State Government, Alzheimer's Australia NSW estimates the number of Australians diagnosed with dementia will rise from 280,000 to around 943,000 by 2050. Of these, 303,500 people will be from NSW.
› Verified 8 days ago